As observed in Fig. 1d, ITGA2 expression is localized on the plasma membranes of the three GBM cell lines (A172, U87, and U118) but absent on SVG-P12 cells, which is readily accessible to ITGA2 antibody-directed nanomedicines. The gene discussed is ITGA2; the disease is glioblastoma.